We also observed enrichment of risk SNPs in binding sites for NfκB and TNF (p<0.0001); variation within these two pathways have also been shown to associate with non-Hodgkin’s lymphoma risk [32]. Here, NFKB1 is linked to non-Hodgkin lymphoma.